Related Experiment Videos
Retinal complications during interferon therapy for chronic hepatitis C
1Second Department of Internal Medicine, Miyazaki Medical College, Japan.
The American Journal of Gastroenterology
|February 1, 1996
Summary
Interferon (IFN) therapy for hepatitis C can cause retinopathy, affecting over half of patients. Close monitoring for retinal changes is crucial during treatment, especially for those with diabetes or hypertension.
Area of Science:
- Ophthalmology
- Hepatology
- Pharmacology
Background:
- Interferon (IFN) therapy is a common treatment for chronic hepatitis C.
- Various side effects of IFN therapy are known, but retinal changes require further investigation.
Purpose of the Study:
- To examine the occurrence and characteristics of retinal changes during interferon therapy in patients with chronic hepatitis C.
Main Methods:
- Ophthalmological examinations were conducted on 63 patients before, during, and after receiving natural or recombinant IFN-alpha therapy.
- Patients with chronic hepatitis C were assessed for retinal abnormalities.
Main Results:
- Retinopathy developed in 57.1% of patients during IFN therapy, including retinal hemorrhage and cotton-wool spots.
- Retinal abnormalities appeared early, within 4-8 weeks of treatment initiation.
- Diabetic and hypertensive patients showed a higher incidence of retinopathy.
Conclusions:
- Interferon therapy frequently leads to retinopathy in chronic hepatitis C patients.
- Close ophthalmological monitoring is recommended during IFN treatment to detect and manage retinal complications.